DE3582124D1 - Absorbierbares calcitoninarzneimittel. - Google Patents
Absorbierbares calcitoninarzneimittel.Info
- Publication number
- DE3582124D1 DE3582124D1 DE8585308583T DE3582124T DE3582124D1 DE 3582124 D1 DE3582124 D1 DE 3582124D1 DE 8585308583 T DE8585308583 T DE 8585308583T DE 3582124 T DE3582124 T DE 3582124T DE 3582124 D1 DE3582124 D1 DE 3582124D1
- Authority
- DE
- Germany
- Prior art keywords
- calcitonine
- absorbable
- medicinal product
- medicinal
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24889884 | 1984-11-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3582124D1 true DE3582124D1 (de) | 1991-04-18 |
Family
ID=17185073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8585308583T Expired - Fee Related DE3582124D1 (de) | 1984-11-26 | 1985-11-26 | Absorbierbares calcitoninarzneimittel. |
Country Status (4)
Country | Link |
---|---|
US (2) | US4690952A (de) |
EP (2) | EP0183527B1 (de) |
JP (1) | JPS61267528A (de) |
DE (1) | DE3582124D1 (de) |
Families Citing this family (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2546407B1 (fr) * | 1983-05-24 | 1986-04-18 | Therapeutique Applic Sa | Medicament a activite anti-allergique pour administration locale a base d'acide n-acetyl(a,b)-aspartyl glutamique |
HU198626B (en) * | 1986-05-27 | 1989-11-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient |
MY102411A (en) * | 1986-12-23 | 1992-06-17 | Ciba Geigy Ag | Nasal solutions |
AU618517B2 (en) * | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
US5059587A (en) * | 1987-08-03 | 1991-10-22 | Toyo Jozo Company, Ltd. | Physiologically active peptide composition for nasal administration |
US4804541A (en) * | 1987-08-11 | 1989-02-14 | Moleculon, Inc. | Transdermal administration using benzyl alcohol |
IT1223132B (it) * | 1987-11-13 | 1990-09-12 | Isf Spa | Composizione farmaceutica per somministrazione nasale |
EP0327756B1 (de) * | 1987-11-13 | 1994-01-26 | Smithkline Beecham Farmaceutici S.p.A. | Ein Calcitonin sowie ein Glycyrrhizinat als Absorptionsförderer enthaltende Arzneimittel |
NO179479C (no) * | 1988-03-11 | 1996-10-16 | Teikoku Seiyaku Kk | Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat |
US5026825A (en) * | 1988-09-08 | 1991-06-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Intranasal calcitonin formulations |
US4950664A (en) † | 1988-09-16 | 1990-08-21 | Rugby-Darby Group Companies, Inc. | Nasal administration of benzodiazepine hypnotics |
USRE36744E (en) * | 1988-09-16 | 2000-06-20 | Ribogene, Inc. | Nasal administration of benzodiazepine hypnotics |
JPH02104531A (ja) * | 1988-10-14 | 1990-04-17 | Toyo Jozo Co Ltd | 経鼻投与用生理活性ペプチド組成物 |
JPH02174726A (ja) * | 1988-12-23 | 1990-07-06 | Toyo Jozo Co Ltd | エルカトニン水溶液組成物の安定化法 |
AT391269B (de) * | 1988-12-30 | 1990-09-10 | Burghart Kurt | Pharmazeutische zubereitung |
AU5194990A (en) * | 1989-02-23 | 1990-09-26 | Rorer International (Holdings), Inc. | Therapeutic aerosol formulations |
IT8920486A0 (it) * | 1989-05-12 | 1989-05-12 | Isf Spa | Composizioni farmaceutiche. |
JP2514249B2 (ja) * | 1989-05-23 | 1996-07-10 | 帝人株式会社 | 安定化されたカルシトニン類医薬組成物 |
JP2911496B2 (ja) * | 1989-09-11 | 1999-06-23 | 帝國製薬株式会社 | 生理活性ポリペプチド含有高吸収性経膣剤 |
IT1237197B (it) * | 1989-11-16 | 1993-05-26 | Sclavo Spa | Formulazioni farmaceutiche anidre e forme di dosaggio per la somministrazione rettale di calcitonina. |
DE69129110T2 (de) * | 1990-05-10 | 1998-12-10 | Bechgaard International Research And Development A/S, Hellerup | Pharmazeutische zubereitung enthaltend n-glykofurole und n-äthylenglykole |
US5397771A (en) * | 1990-05-10 | 1995-03-14 | Bechgaard International Research And Development A/S | Pharmaceutical preparation |
JPH078806B2 (ja) * | 1990-08-16 | 1995-02-01 | 旭化成工業株式会社 | カルシトニン類含有経鼻投与用乳剤 |
GB9108634D0 (en) * | 1991-04-23 | 1991-06-12 | Ciba Geigy | Pharmaceutical compositions |
IT1251685B (it) * | 1991-10-11 | 1995-05-19 | Isf Spa | Composizioni farmaceutiche contenenti una calcitonina |
US5571788A (en) * | 1991-12-09 | 1996-11-05 | Ciba-Geigy Corporation | Stable calcitonin pharmaceutical compositions |
US5747445A (en) * | 1993-06-24 | 1998-05-05 | Astra Aktiebolag | Therapeutic preparation for inhalation |
IS1796B (is) * | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
US6632456B1 (en) | 1993-06-24 | 2003-10-14 | Astrazeneca Ab | Compositions for inhalation |
US20010003739A1 (en) * | 1993-06-24 | 2001-06-14 | Astrazeneca Ab | Systemic administration of a therapeutic preparation |
TW402506B (en) * | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
US5830853A (en) | 1994-06-23 | 1998-11-03 | Astra Aktiebolag | Systemic administration of a therapeutic preparation |
US6794357B1 (en) * | 1993-06-24 | 2004-09-21 | Astrazeneca Ab | Compositions for inhalation |
DE69430132T2 (de) * | 1993-10-21 | 2002-08-29 | Hisamitsu Pharmaceutical Co., Inc. | Pernasale zusammensetzung und diese enthaltende pernasale zubereitung |
US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
US6165976A (en) * | 1994-06-23 | 2000-12-26 | Astra Aktiebolag | Therapeutic preparation for inhalation |
SE9404468D0 (sv) * | 1994-12-22 | 1994-12-22 | Astra Ab | Powder formulations |
US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
PL320856A1 (en) | 1994-12-22 | 1997-11-10 | Astra Ab | Aerosol drug preparations |
AU703532B2 (en) * | 1994-12-22 | 1999-03-25 | Astra Aktiebolag | Therapeutic preparation for inhalation containing parathyroid hormone, PTH |
DE19503190A1 (de) * | 1995-02-01 | 1996-08-08 | Dietl Hans | Mittel zur Beeinflussung von Störungen der Knochenbildung |
DE726075T1 (de) * | 1995-02-08 | 1996-12-12 | Therapicon Srl | Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung |
US5653987A (en) * | 1995-05-16 | 1997-08-05 | Modi; Pankaj | Liquid formulations for proteinic pharmaceuticals |
EP0983769A4 (de) | 1997-04-14 | 2002-05-02 | Mitsubishi Tokyo Pharm Inc | Permucose formulierung |
SE9702401D0 (sv) | 1997-06-19 | 1997-06-19 | Astra Ab | Pharmaceutical use |
IT1294191B1 (it) * | 1997-09-05 | 1999-03-22 | Alfa Wassermann Spa | Composizioni farmaceutiche contenenti calcitonina in un dosatore spray per somministrazione intranasale. |
US6017545A (en) * | 1998-02-10 | 2000-01-25 | Modi; Pankaj | Mixed micellar delivery system and method of preparation |
US6221378B1 (en) | 1998-02-10 | 2001-04-24 | Generex Pharmaceuticals Incorporated | Mixed micellar delivery system and method of preparation |
US7070799B1 (en) * | 1998-02-10 | 2006-07-04 | Generex Pharmaceuticals, Inc. | Method for administering insulin to the buccal region |
KR100345214B1 (ko) * | 1999-08-17 | 2002-07-25 | 이강춘 | 생체적합성 고분자가 수식된 펩타이드의 비점막 전달 |
EP1251867A4 (de) | 2000-02-04 | 2004-12-08 | Unigene Lab Inc | Nasale calcitoninformulierungen |
AU4920701A (en) * | 2000-03-14 | 2001-09-24 | Nat Jewish Med & Res Center | Method for reducing allergen-induced airway hyperresponsiveness |
GB2368792A (en) * | 2000-10-06 | 2002-05-15 | Roger Randal Charles New | Absorption enhancers |
US20030017181A1 (en) | 2001-05-31 | 2003-01-23 | Rood Gloria A. | Dermatological compositions and methods |
DE60330698D1 (de) * | 2002-08-28 | 2010-02-04 | Lupin Ltd | Kräuterextrakt aus sapindus trifoliatus, enthaltend eine mischung aus saponinen mit krampflösender wirkung |
JP4543274B2 (ja) * | 2002-10-01 | 2010-09-15 | 大正製薬株式会社 | 点鼻剤組成物 |
WO2004084859A2 (en) | 2003-03-21 | 2004-10-07 | Nastech Pharmaceutical Company Inc. | Nasal calcitonin formulations containing chlorobutanol |
GB0308732D0 (en) * | 2003-04-15 | 2003-05-21 | Axcess Ltd | Absorption enhancers |
GB0308734D0 (en) | 2003-04-15 | 2003-05-21 | Axcess Ltd | Uptake of macromolecules |
GB2417202A (en) * | 2004-08-16 | 2006-02-22 | Cipla Ltd | Pharmaceutical preparation comprising calcitonin |
US20090258865A1 (en) | 2008-03-28 | 2009-10-15 | Hale Biopharma Ventures, Llc | Administration of benzodiazepine compositions |
PT3415139T (pt) * | 2011-06-14 | 2022-06-20 | Neurelis Inc | Administração de benzodiazepina |
IN2014CN03214A (de) | 2011-10-21 | 2015-07-03 | Seachaid Pharmaceuticals Inc |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4151276A (en) * | 1975-05-12 | 1979-04-24 | Armour Pharmaceutical Company | Method of suppressing gastric acid secretion by the oral administration of calcitonin |
CA1098444A (en) * | 1975-05-26 | 1981-03-31 | Leo Geller | Peptide preparations with prolonged action |
GB1554157A (en) * | 1975-06-13 | 1979-10-17 | Takeda Chemical Industries Ltd | Stable insulin preparation for intra nasal administration |
DE3171774D1 (en) * | 1980-03-31 | 1985-09-19 | Teijin Ltd | Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom |
GB2127689B (en) * | 1982-10-05 | 1986-07-09 | Sandoz Ltd | Calcitonin inhalation compositions |
AU572815B2 (en) * | 1982-12-29 | 1988-05-19 | Armour Pharmaceutical Company | Pharmaceutical calcitonin compositions for intranasal application |
JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
CH657858A5 (de) * | 1983-06-27 | 1986-09-30 | Ciba Geigy Ag | Substanz aus der gruppe der calcitonine. |
GB8407907D0 (en) * | 1984-03-27 | 1984-05-02 | Sandoz Ltd | Organic compounds |
-
1985
- 1985-11-21 JP JP60263544A patent/JPS61267528A/ja active Pending
- 1985-11-22 US US06/800,983 patent/US4690952A/en not_active Expired - Fee Related
- 1985-11-26 EP EP85308583A patent/EP0183527B1/de not_active Expired
- 1985-11-26 EP EP90200083A patent/EP0371010A1/de not_active Withdrawn
- 1985-11-26 DE DE8585308583T patent/DE3582124D1/de not_active Expired - Fee Related
-
1987
- 1987-05-05 US US07/046,278 patent/US4788221A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4690952A (en) | 1987-09-01 |
EP0183527B1 (de) | 1991-03-13 |
EP0183527A3 (en) | 1987-09-23 |
EP0183527A2 (de) | 1986-06-04 |
US4788221A (en) | 1988-11-29 |
EP0371010A1 (de) | 1990-05-30 |
JPS61267528A (ja) | 1986-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3582124D1 (de) | Absorbierbares calcitoninarzneimittel. | |
DE3667381D1 (de) | Absorbierendes erzeugnis. | |
DE3774264D1 (de) | Pseudoephedrin-dosierungsform. | |
DE3671363D1 (de) | Papierwindel. | |
FI875326A0 (fi) | Ljusbestraolningsanordning foer medicinal vaord av oera. | |
DE3889269D1 (de) | Thermoplastische Zusammensetzung. | |
FI893340A (fi) | Foerfarande foer att erhaolla farmaceutiska sammansaettningar foer att hindra smittbara koenssjukdomar. | |
DE3485408D1 (de) | Pharmazeutische zusammensetzung. | |
NO873999D0 (no) | Dose-dispenser. | |
FI854573A0 (fi) | Farmaceutiska kapslar med foerdroejd frigoering. | |
NO882653D0 (no) | Doseringsform. | |
FI850946L (fi) | Medicinska plaoster. | |
TR25202A (tr) | Gelistirilmis polietilen hamuru. | |
DE3581730D1 (de) | Menschlicher tumornekrosisfaktor. | |
DE3851465D1 (de) | Schalter. | |
FI883673A0 (fi) | Farmaceutiska kompositioner. | |
FI862590A (fi) | Farmaceutiska produkter. | |
FI850455L (fi) | Farmaceutiska produkter. | |
FI853249A0 (fi) | Cdna-kloner foer human erytropoietin. | |
FI840392A (fi) | Hygieniskt engaongsfoeremaol foer inkontinenta personer. | |
FI875167A0 (fi) | Kallvalsad bandstaolprodukt. | |
NO883214L (no) | Utporsjoneringsanordning. | |
DE3763519D1 (de) | Heilnahrungsmittel. | |
DK330584A (da) | Paedagogisk legesaet | |
DE3483478D1 (de) | Schalter. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |